DiaMedica Therapeutics Inc.
Organization details
- Legal name
- DiaMedica Therapeutics Inc.
- Former names
- DiaMedica Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Canada (Federal Level)
- Headquarters city
- Minneapolis
- Headquarters state / province
- Minnesota
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DMAC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001401040
Board of directors
-
Amy L. Burroughs · DirectorSince 2023
-
Charles Pauling Semba · DirectorSince 2023
-
Daniel J. O'Connor · DirectorSince 2025
-
Dietrich John Pauls · Director · President & CEOSince 2023
-
James T. Parsons · DirectorSince 2023
-
Randall Michael Giuffre · DirectorSince 2023
-
Richard D. Pilnik · DirectorSince 2023
-
Richard Kuntz · DirectorSince 2023
-
Tanya Lewis · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
50.4%
-
97.0%
-
98.0%
-
98.2%
Board connections
3 of this board's directors also sit on 3 other boards. 2 are in the same sector.
- via Richard Kuntz
-
Oncolytics Biotech Inc. Same sectorvia James T. Parsons
-
Tenaya Therapeutics Inc. Same sectorvia Amy L. Burroughs
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $7,632,627
- 7 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Dietrich John Pauls Director, Officer (President & CEO) | Grant or award | +60,200 | — | — |
| Jan 2, 2026 | James T. Parsons Director | Grant or award | +10,095 | $8.42 | $85,000 |
| Jan 2, 2026 | Randall Michael Giuffre Director | Grant or award | +6,175 | $8.42 | $51,994 |
| Jan 2, 2026 | Charles Pauling Semba Director | Grant or award | +3,355 | $8.42 | $28,249 |
| Nov 25, 2025 | TRILL AB 10% owner | Open-market purchase | +73,099 | $8.57 | $626,458 |
| Nov 24, 2025 | TRILL AB 10% owner | Open-market purchase | +40,253 | $7.89 | $317,596 |
| Nov 21, 2025 | James T. Parsons Director | Option exercise | +12,000 | $2.20 | $26,400 |
| Nov 21, 2025 | TRILL AB 10% owner | Open-market purchase | +208,872 | $7.41 | $1,547,742 |
| Nov 20, 2025 | TRILL AB 10% owner | Open-market purchase | +128,426 | $7.41 | $951,637 |
| Nov 19, 2025 | TRILL AB 10% owner | Open-market purchase | +240,352 | $7.21 | $1,732,938 |
| Nov 18, 2025 | TRILL AB 10% owner | Open-market purchase | +182,882 | $6.75 | $1,234,454 |
| Nov 17, 2025 | TRILL AB 10% owner | Open-market purchase | +187,393 | $6.52 | $1,221,802 |
| Aug 27, 2025 | STAHLBERG JAN 10% owner | Open-market purchase | +50,772 | $6.00 | $304,632 |
| Aug 26, 2025 | STAHLBERG JAN 10% owner | Open-market purchase | +59,648 | $6.00 | $357,888 |
| Aug 25, 2025 | STAHLBERG JAN 10% owner | Open-market purchase | +338,265 | $6.00 | $2,029,590 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about DiaMedica Therapeutics Inc.
Who is the CEO of DiaMedica Therapeutics Inc.?
Dietrich John Pauls is DiaMedica Therapeutics Inc.'s President and CEO.
How many directors are on DiaMedica Therapeutics Inc.'s board?
DiaMedica Therapeutics Inc.'s board has 9 directors: Amy L. Burroughs, Charles Pauling Semba, Daniel J. O'Connor, Dietrich John Pauls, James T. Parsons, Randall Michael Giuffre, Richard D. Pilnik, Richard Kuntz and Tanya Lewis.
Are DiaMedica Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, DiaMedica Therapeutics Inc. insiders bought $7.6 million of shares in 7 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="diamedica-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.